Advancing Pediatric Research in the COVID-19 Era

As the COVID-19 pandemic continues to spread across the world, reports on the unique experience of COVID-19 in children are starting to emerge. Most recently, a rare, but serious condition has been recognized called Multisystem inflammatory syndrome in children (MIS-C), a complication of Covid-19 infection.

While children were initially thought to be largely spared from Covid-19 most serious effects, new studies highlight the critical need for pediatric research – from treatments to vaccines. Please join Sally Allain, Head of JLABS @ Washington, DC, with Dr. David Wessel, Chief Medical Officer at Children's National Hospital, Dr. Roberta L. DeBiasi, Chief of the Division of Pediatric Infectious Diseases at Children’s National Hospital and Dr. Samuel Maldonado, Head of Pediatric Drug Development and Vice President, Child Health Innovation Leadership Department at Johnson & Johnson. The conversation will focus on the latest Covid-19 pediatric science – and what incentives might speed answers for children, their families and communities through this pandemic and beyond.

Check out more On-Demand Webinars

The information on this webpage, including in the videos, is proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies (“JJI”) and is for informational purposes only. This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of Johnson & Johnson or its affiliates. The information presented in the videos is specific and applicable to region in which the original presentation took place. Many videos contain information from, or sessions given by, third parties. Please note that only those third parties that provide this information are responsible for it. By providing this information, JJI does not endorse these third parties or any of the information provided in these videos, and JJI makes no representations, warranties, or assurances, express or implied, as to the content or the information presented and is not responsible for any use of this information by you.